Skip to main content
. 2021 Jul 28;71(3):661–674. doi: 10.1007/s00262-021-03021-3

Fig. 2.

Fig. 2

Both preoperative exoPD-L1 and sPD-L can be used as biomarkers of survival. Kaplan–Meier estimation of A relapse-free survival (p = 0.0043) and B overall survival (p = 0.0034) in patients according to preoperative exoPD-L1 levels; Kaplan–Meier estimation of C relapse-free survival (p = 0.0041) and D overall survival (p = 0.0061) in patients according to preoperative sPD-L1